Fatigue, a common complaint in medical practice, is often a complex and multifaceted condition. It can be a symptom of numerous underlying conditions, making diagnosis and management a challenging task for physicians. This article aims to provide a comprehensive clinical approach to diagnosing and managing fatigue.
A detailed patient history and physical examination are the cornerstones of fatigue assessment. The duration, severity, onset, and any associated symptoms should be thoroughly investigated. Additionally, evaluating psychosocial factors and lifestyle habits can provide valuable insights into potential contributing factors. Relevant laboratory tests may be necessary to rule out conditions like anemia, thyroid disorders, or chronic infections.
Given the broad differential diagnosis for fatigue, a systematic approach is essential. This often involves ruling out common medical causes first, such as endocrine or hematologic disorders. If these are absent, the next step is to consider psychiatric disorders like depression or anxiety. If no clear cause is identified, the diagnosis of chronic fatigue syndrome (CFS) may be considered, using established criteria.
Treatment should be tailored to the underlying cause of fatigue. This may involve pharmacological interventions, lifestyle modifications, or psychological therapies. For patients diagnosed with CFS, cognitive behavioral therapy and graded exercise therapy have shown promising results. However, the management of fatigue often requires a multidisciplinary approach, involving physicians, psychologists, and physiotherapists.
Understanding and managing fatigue can be a complex process, due to its multifactorial nature and the wide range of potential underlying conditions. A systematic and comprehensive approach to its diagnosis and treatment is crucial. Further research is needed to enhance our understanding of fatigue and develop more effective management strategies.
1.
Research uncovers hidden Australian skin cancer epidemic
2.
What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?
3.
The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.
4.
Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise.
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Understanding Purpura Fulminans: Causes, Symptoms and Treatment Options
2.
The Importance of Maintaining Normal Calcium Levels in Your Body
3.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
4.
Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities
5.
A Comprehensive Guide to Carcinoma in Situ: Types, Risks, and Preventive Measures
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
2.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
5.
Latest Advances in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation